Best in Biotech 6 Jun 2024
Eight biotech companies advancing the field of siRNA
Explore the growing sector of siRNA and discover eight biotech companies spearheading this innovative field.
- Latest Posts
In Depth 5 Jun 2024
Evolving standards of care: new treatments for cervical cancer
New treatments for cervical cancer aim to broaden therapeutic options, and improve current standards of care for patients.
Best in Biotech 4 Jun 2024
Ohio’s finest: Eight biotech companies leading the way
While Ohio has a strong emphasis on manufacturing, the state is home to several innovative biotech companies.
In Depth 3 Jun 2024
The biggest private biotech investments in May 2024
The companies Uniquity Bio, AltruBio, and BridgeBio Oncology Therapeutics bagged the biggest private biotech investments in May 2024.
Best in Biotech 31 May 2024
Biotech career fairs in the U.S. you don’t want to miss
Biotech career fairs are held to connect talent with professionals and recruiters. Here are six popular events that take place annually in the U.S.
Podcast 31 May 2024
Can cell therapy tackle hearing loss
Hearing loss is a growing global challenge. UK-based Rinri Therapeutics is developing a portfolio of off-the-shelf regenerative cell therapy products to address sensorineural hearing loss.
ADVERTISEMENT
ADVERTISEMENT
In Depth 30 May 2024
Covalent biologics: a new class of drugs on the horizon
The field of covalent biologics has made headway recently, as the only biotech in the space has bagged $100 million to move its pipeline to the clinic.
Best in Biotech 30 May 2024
Stem cell therapy’s avant-garde: Eight companies leading the way
Stem cell therapy has gained traction over the recent years and the market is growing, discover eight companies advancing the field.
Best in Biotech 28 May 2024
8 Swedish companies spearheading the country’s biotech scene
As Sweden’s life sciences sector continues to grow, we explore 8 biotech companies in Sweden that are leading the way in the industry.
More News! 27 May 2024
New report shows that Swiss biotech capital investment surged last year
With a record revenue of $8 billion in 2023, Swiss biotech appears robust in 2024. Delve into the findings of the Swiss Biotech Report 2024.
Expert Advice 24 May 2024
Mission statement, the key to success for biotech companies
Mission statement, purpose and vision are essential to the success of a biotech. Delve into the stategies to build on company culture.
Podcast 24 May 2024
How biotech is tackling myasthenia gravis
To talk about the disease, how it is being treated, and what is in the pipeline for future treatments, we had a conversation with Dana Vigier, head of Central Eastern and Northern Europe at Alexion.
ADVERTISEMENT
